Literature DB >> 12932065

Epidural levobupivacaine, ropivacaine and bupivacaine in combination with sufentanil in early labour: a randomized trial.

M Camorcia1, G Capogna.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the efficacy, delay and duration of analgesia of three equianalgesic epidural doses of levobupivacaine, ropivacaine and bupivacaine during the first stage of labour.
METHODS: One hundred and twenty-nine healthy primigravida in spontaneous labour who requested epidural analgesia were enrolled in a randomized observer-blinded study. Parturients were allocated to receive epidural levobupivacaine 0.0625%, ropivacaine 0.1% or bupivacaine 0.06259%. Sufentanil 10 microg was added to all solutions; the total volume of epidural solution was 20 mL. Pain was measured using a 100 mm visual analogue pain scale immediately before the epidural block, and at 5, 10, 15, 20 and 30 min thereafter. Motor block was evaluated using a modified Bromage scoring system. The adequacy of motor function for ambulation was also evaluated. Delay of analgesia was the time interval between the injection of the solution and the first painless contraction. Duration of analgesia was the time from the first painless contraction to the parturients' requests for further analgesia.
RESULTS: Twelve parturients failed to complete the study. Eleven parturients had inadequate analgesia (four in Group Levobupivacaine, four in Group Ropivacaine and three in Group Bupivacaine; P > 0.05). Data was analysed from 34 parturients in Group Levobupivacaine, from 37 in Group Ropivacaine and from 35 in Group Bupivacaine. There were no differences in the delay of analgesia or in the number of parturients who were able to walk unaided. Levobupivacaine and ropivacaine produced more prolonged analgesia than bupivacaine (114 and 119 min, respectively, versus 89 min; P < 0.01).
CONCLUSIONS: During early labour, equipotent low concentrations of levobupivacaine, ropivacaine and bupivacaine, all with the addition of sufentanil 10 microg, produced similar pain relief and motor block, but levobupivacaine and ropivacaine produced a longer lasting analgesia. About 10% of parturients had inadequate analgesia with a single bolus of the tested solutions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932065     DOI: 10.1017/s0265021503001029

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  7 in total

Review 1.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

Review 3.  Levobupivacaine: a review of its use in regional anaesthesia and pain management.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

Review 4.  [Levobupivacaine in obstetric analgesia and anaesthesia. Where is its place?].

Authors:  D H Bremerich; B Zwissler
Journal:  Anaesthesist       Date:  2004-07       Impact factor: 1.041

5.  Comparison of Three Different Concentrations of Levobupivacaine for Epidural Labor Analgesia: Clinical Effect and Pharmacokinetic Profile.

Authors:  Ahmed Mostafa El-Shaarawy; Mohamed S Asfour; Doaa A Rashwan; Mahmoud M Amer; Shahira F El-Menshawe; Mohammed H Elkomy
Journal:  Anesth Essays Res       Date:  2018 Jan-Mar

6.  A Comparison Between Dexmedetomidine and Clonidine as Adjuvants to Levobupivacaine in Labour Analgesia.

Authors:  Shruti Kabi; Reetu Verma; Dinesh Singh; Premraj Singh; Jyotsna Agarwal; Brij Bihari Kushwaha; Ajay K Chaudhary; Nisha Singh
Journal:  Cureus       Date:  2021-12-07

7.  Clinical profile of levobupivacaine in regional anesthesia: A systematic review.

Authors:  Sukhminder Jit Singh Bajwa; Jasleen Kaur
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.